Integrated program takes aim at co-morbidity

Ocaliva and resmetirom may be approved by the FDA this year.

This month’s episode of the "What's On Your Mind" podcast series features Eric Hunter, president and CEO of CareOregon. MHE Managing Editor Peter Wehrwein, Editor Briana Contreras and Hunter discuss Medicaid redetermination and merger of CareOregon and the California-based insurer, SCAN Group.

Results of Sanofi-sponsored study presented at ISPOR meeting also show lower hospitalization rates among app users.

This month's episode of Tuning In to the C-Suite features Erica Jain, CEO & co-founder of digital health company, Healthie. In this discussion, Jain shared some of the challenges or things to avoid when creating a digital health startup, based on her journey with starting Healthie in 2016. She also addressed some best practices and tools that can help those working toward a digital health startup.

Weekly surveillance monitoring, also known as rapid cycle analysis, of more than 245,000 COVID-19 mRNA vaccine doses did not detect a safety signal for any outcome in the 21 days after vaccination.

Health plan leaders should act quickly to implement cost of care strategies to help offset future Medicaid-related revenue losses. Steps they can take include careful reviews of pricing and of medical management to make sure that the services are medically appropriate and necessary.